| INrf2 (Keap1) targets Bcl-2 degradation and controls cellular apoptosis. | |
| | |
MedLine Citation:
|
PMID: 20865015 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cytosolic inhibitor of Nrf2 (INrf2) is an adaptor protein that mediates ubiquitination/degradation of NF-E2-related factor 2 (Nrf2), a master regulator of cytoprotective gene expression. In this paper, we demonstrate that INrf2 degrades endogenous antiapoptotic B-cell CLL/lymphoma 2 (Bcl-2) protein and controls cellular apoptosis. The DGR domain of INrf2 interacts with the BH2 domain of Bcl-2 and facilitates INrf2:Cul3-Rbx1-mediated ubiquitination of Bcl-2 by the conjugation of ubiquitin molecules to lysine17 of Bcl-2. Further studies showed that INrf2 enhanced etoposide-mediated accumulation of Bax, increased release of cytochrome c from mitochondria, activated caspase-3/7, and enhanced DNA fragmentation and apoptosis. Antioxidants antagonized Bcl-2:INrf2 interaction, led to the release and stabilization of Bcl-2, increased Bcl-2:Bax heterodimers and reduced apoptosis. Moreover, dysfunctional/mutant INrf2 in human lung cancer cells failed to degrade Bcl-2, resulting in decreased etoposide and UV/γ radiation-mediated DNA fragmentation. These data provide the first evidence of INrf2 control of Bcl-2 and apoptotic cell death, with implications in antioxidant protection, survival of cancer cells containing dysfunctional INrf2, and drug resistance. |
| | |
Authors:
|
S K Niture; A K Jaiswal |
Related Documents
:
|
8898945 - Distinct mechanisms for rescue from apoptosis in ramos human b cells by signaling throu... 11029315 - Beta-adrenergic receptor/camp-mediated signaling and apoptosis of s49 lymphoma cells. 18292495 - Cutting edge: contributions of apoptosis and anergy to systemic t cell tolerance. 9922095 - Intracellular mechanisms of ovarian cell apoptosis. 16622035 - Stat3 and nf-kappab signal pathway is required for il-23-mediated il-17 production in s... 17388785 - Enteropathogenic escherichia coli (epec) inactivate innate immune responses prior to co... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural Date: 2010-09-24 |
Journal Detail:
|
Title: Cell death and differentiation Volume: 18 ISSN: 1476-5403 ISO Abbreviation: Cell Death Differ. Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-02-14 Completed Date: 2011-05-31 Revised Date: 2012-09-18 |
Medline Journal Info:
|
Nlm Unique ID: 9437445 Medline TA: Cell Death Differ Country: England |
Other Details:
|
Languages: eng Pagination: 439-51 Citation Subset: IM |
Affiliation:
|
Department of Pharmacology and Experimental Therapeutics, University of Maryland School of Medicine, Baltimore, MD 21201, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adaptor Proteins, Signal Transducing
/
metabolism* Animals Antioxidants / metabolism Apoptosis* / drug effects, radiation effects Carrier Proteins / metabolism Cell Line, Tumor Cell Survival / drug effects, radiation effects Cullin Proteins / metabolism Cytoskeletal Proteins / metabolism* DNA Fragmentation / drug effects, radiation effects Etoposide / pharmacology Gamma Rays Humans Hydroquinones / pharmacology Intracellular Signaling Peptides and Proteins / metabolism* Lung Neoplasms / metabolism, pathology Lysine / metabolism Mice Phosphorylation / drug effects, radiation effects Phosphoserine / metabolism Protein Binding / drug effects, radiation effects Protein Processing, Post-Translational* / drug effects, radiation effects Protein Stability / drug effects, radiation effects Protein Structure, Tertiary Proto-Oncogene Proteins c-bcl-2 / chemistry, metabolism* Ubiquitination / drug effects, radiation effects Ultraviolet Rays Up-Regulation / drug effects, radiation effects bcl-2-Associated X Protein / metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
R01 ES012265/ES/NIEHS NIH HHS; R01 ES012265-07/ES/NIEHS NIH HHS; R01 ES012265-08/ES/NIEHS NIH HHS; R01 ES012265-09/ES/NIEHS NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Adaptor Proteins, Signal Transducing; 0/Antioxidants; 0/Carrier Proteins; 0/Cullin Proteins; 0/Cytoskeletal Proteins; 0/Hydroquinones; 0/Intracellular Signaling Peptides and Proteins; 0/KEAP1 protein, human; 0/Keap1 protein, mouse; 0/Proto-Oncogene Proteins c-bcl-2; 0/bcl-2-Associated X Protein; 17885-08-4/Phosphoserine; 1948-33-0/2-tert-butylhydroquinone; 33419-42-0/Etoposide; 56-87-1/Lysine |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Coordinated waves of gene expression during neuronal differentiation of embryonic stem cells as basi...
Next Document: Mechanisms of force generation and force transmission during interstitial leukocyte migration.